Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

PET Imaging Compound Highlights Amyloid Plaques
Jul 2002
STOCKHOLM, Sweden, July 25 -- A compound used with positron emission tomography (PET) imaging may enable researchers to detect amyloid plaques in the brains of individuals in the early stages of Alzheimer's disease.

Using microscopic "multiphoton" imaging technology and transgenic mice -- mice genetically engineered to develop amyloid plaques similar to those in Alzheimer's disease -- researchers found that the compound 6-OH-BTA-1 distinguishes individual amyloid plaques in the brain of a living animal model of Alzheimer's disease. The method holds promise for use in studying individuals with Alzheimer's disease, the researchers say.

Scientists previously could view amyloid plaques -- one of the pathological hallmarks of Alzheimer's -- only during an autopsy.

The research team is made up of scientists from the University of Pittsburgh School of Medicine, Massachusetts General Hospital, Uppsala University PET Center, and Karolinska Institute in Sweden. The Alzheimer's Association and National Institute on Aging provided grant support for the research, conducted at University of Pittsburgh.

News & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x We deliver – right to your inbox. Subscribe FREE to our newsletters.